Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Cannabinoids for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: a systematic review and meta-analysis

Published:2017-02-23 Issue:4 Volume:119 Page:515-521
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Abo Youssef Nadim¹,Schneider Marc P.¹²³,Mordasini Livio⁴,Ineichen Benjamin V.²³,Bachmann Lucas M.⁵,Chartier-Kastler Emmanuel⁶,Panicker Jalesh N.⁷,Kessler Thomas M.¹

Affiliation:

1. Neuro-Urology, Spinal Cord Injury Center and Research; Balgrist University Hospital; University of Zürich; Zürich Switzerland

2. Brain Research Institute; University of Zürich; Zürich Switzerland

3. Department of Health Sciences and Technology; Swiss Federal Institute of Technology Zürich; Zürich Switzerland

4. Department of Urology; Cantonal Hospital Lucerne; Lucerne Switzerland

5. Medignition Inc., Research Consultants; Zürich Switzerland

6. Department of Urology; Academic Hospital Pitié-Salpêtrière; Assistance Publique-Hôpitaux de Paris; Pierre et Marie Curie Medical School; Sorbonne Universités; Paris 6 University; Paris France

7. Department of Uro-Neurology; National Hospital for Neurology and Neurosurgery and UCL Institute of Neurology; London UK

Funder

Swiss Continence Foundation

UK's Department of Health National Institute of Health Research Biomedical Research Centres

Schweizerische Akademie der Medizinischen Wissenschaften

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.13759/fullpdf

Reference24 articles.

1. Lower urinary tract dysfunction in the neurological patient: clinical assessment and management;Panicker;Lancet Neurol,2015

2. Summary of European Association of Urology (EAU) guidelines on neuro-urology;Groen;Eur Urol,2016

3. The neurogenic bladder in multiple sclerosis: review of the literature and proposal of management guidelines;Seze;Mult Scler,2007

4. The cannabinoid acids, analogs and endogenous counterparts;Burstein;Bioorg Med Chem,2014

5. Cannabinoids control spasticity and tremor in a multiple sclerosis model;Baker;Nature,2000

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Summary of the 2024 Update of the European Association of Urology Guidelines on Neuro-urology;European Urology;2024-06

2. Neuro-urologische Diagnostik und Therapie nicht traumatischer/degenerativ bedingter neurogener Dysfunktion des unteren Harntraktes am Beispiel der Multiplen Sklerose;Aktuelle Urologie;2024-04-23

3. Proteome-Wide Profiling Using Sample Multiplexing of a Human Cell Line Treated with Cannabidiol (CBD) and Tetrahydrocannabinol (THC);Proteomes;2023-11-02

4. Activation of the Cannabinoid Receptors Suppresses Hyperexcitation of Rat Hippocampal Neuronal Networks In Vitro;Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology;2023-06

5. Activation of the Cannabinoid Receptors Suppresses Hyperexcitation of Rat Hippocampal Neuronal Networks <i>in vitro</i>;Биологические мембраны Журнал мембранной и клеточной биологии;2023-05-01